Development

Covid-19 vaccine tracker, Sept 26: WHO makes financial case for investing in Covax facility


Vaccine headed to India enters phase-3 trials. A coronavirus vaccine being developed by US company Novavax has said it was beginning final stage …

To Read More, Please Visit Source

Related Articles

Back to top button
error: